Human papillomavirus infections in primary care

Clinical Medicine and Research

Volumn 5, Issue 4, 2007, Pages 210-217

  Ogunmodede, Folashade ^a   Yale, Steven H ^a   Krawisz, Bruce ^a   Tyler, Gregory C ^a   Evans, Anthony C ^b  

^a MARSHFIELD CLINIC   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Genital warts; HPV; Pap test

Indexed keywords

IMIQUIMOD; INTERFERON; PODOPHYLLIN; PODOPHYLLOTOXIN; TRICHLOROACETIC ACID; WART VIRUS VACCINE; VIRUS DNA;

BEDTIME DOSAGE; CANCER INVASION; CANCER PREVENTION; CLINICAL EVALUATION; CLINICAL PRACTICE; COLPOSCOPY; CONDYLOMA ACUMINATUM; CRYOTHERAPY; CURETTAGE; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DRUG EFFICACY; EARLY DIAGNOSIS; ELECTROSURGERY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LONG TERM CARE; MULTIPLE CYCLE TREATMENT; PAPANICOLAOU TEST; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRECANCER; REVIEW; RISK FACTOR; SCREENING; SEXUAL TRANSMISSION; SIGMOIDOSCOPY; SQUAMOUS CELL CARCINOMA; TREATMENT CONTRAINDICATION; TREATMENT DURATION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS GENOME; WART VIRUS; FEMALE; GENETICS; INCIDENCE; ISOLATION AND PURIFICATION; PAPILLOMA VIRUS; PRIMARY HEALTH CARE; STATISTICS; UNITED STATES; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

DNA, VIRAL; FEMALE; HUMANS; INCIDENCE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PRIMARY HEALTH CARE; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 42949163605     PISSN: 15394182     EISSN: None     Source Type: Journal    
DOI: 10.3121/cmr.2007.751     Document Type: Review

References (54)

1. Bulletin of the World Health Organization (BLT). World Health Organization Web site. Available at: http://www.who.int/bulletin/volumes/84/2/. Accessed May 22, 2006.
2. Cancer Facts and Figures 2002. American Cancer Society Web site. Available at: http://www.cancer.org/downloads/STT/CancerFacts&Figures2002TM. pdf. Accessed January 24, 2007.
3. Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK, eds. SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. Bethesda, MD. Available at: http://seer.cancer.gov/csr/1975_2003/index.html. Accessed June 20, 2007.
4. Scott JR, Gibbs RS, Karlan BY, Haney AF, eds. Danforth's obstetrics and gynecology, Ninth edition. Philadelphia, PA: Lippincott Williams and Wilkins; 2003.
5. Screening for Cervical Cancer, January 2003. U.S. Preventive Services Task Force Web site. Available at: http://www.ahrq.gov/clinic/uspstf/uspscerv. htm. Accessed January 24, 2007.
6. Smith RA, Cokkinides V, von Eschenbach AC, Levin B, Cohen C, Runowicz CD, Sener S, Saslow D, Eyre HJ; American Cancer Society. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2002;52:8-22.
7. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, Cohen C; American Cancer Society. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342-362.
8. Clifford GM, Smith JS, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003;89:101-105.
9. Einstein MH, Goldberg GL. Human papillomavirus and cervical neoplasia. Cancer Invest 2002;20:1080-1085.
10. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE. Prevalence of HPV infection among females in the United States. JAMA 2007;297:813-819.
11. Tarkowski TA, Koumans EH, Sawyer M, Pierce A, Black CM, Papp JR, Markowitz L, Unger ER. Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population. J Infect Dis 2004;189:46-50.
12. Peyton CL, Gravitt PE, Hunt WC, Hundley RS, Zhao M, Apple RJ, Wheeler CM. Determinants of genital human papillomavirus detection in a US population. J Infect Dis 2001;183:1554-1564.
13. Sellors JW, Karwalajtys TL, Kaczorowski J, Mahony JB, Lytwyn A, Chong S, Sparrow J, Lorincz A; Survey of HPV in Ontario Women Group. Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ 2003;168:421-425.
14. Sellors JW, Mahony JB, Kaczorowski J, Lytwyn A, Bangura H, Chong S, Lorincz A, Dalby DM, Janjusevic V, Keller JL. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ 2000;163:503-508.
15. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-428.
16. Herrero R, Schiffman MH, Bratti C, Hildesheim A, Balmaceda I, Sherman ME, Greenberg M, Cardenas F, Gomez V, Helgesen K, Morales J, Hutchinson M, Mango L, Alfaro M, Potischman NW, Wacholder S, Swanson C, Brinton LA. Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project. Rev Panam Salud Publica 1997;1:362-375.
17. Grainge MJ, Seth R, Guo L, Neal KR, Coupland C, Vryenhoef P, Johnson J, Jenkins D. Cervical human papillomavirus screening among older women. Emerg Infect Dis 2005;11:1680-1685.
18. Baldwin SB, Wallace DR, Papenfuss MR, Abrahamsen M, Vaught LC, Kornegay JR, Hallum JA, Redmond SA, Giuliano AR. Human papillomavirus infection in men attending a sexually transmitted disease clinic. J Infect Dis 2003;187:1064-1070.
19. Castellsague X, Bosch FX, Munoz N, Meijer CJ, Shah KV, de Sanjose S, Eluf-Neto J, Ngelangel CA, Chichareon S, Smith JS, Herrero R, Moreno V, Franceschi S; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002;346:1105-1112.
20. Silverberg MJ, Ahdieh L, Munoz A, Anastos K, Burk RD, Cu-Uvin S, Duerr A, Greenblatt RM, Klein RS, Massad S, Minkoff H, Muderspach L, Palefsky J, Piessens E, Schuman P, Watts H, Shah KV. The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts. Sex Transm Dis 2002;29:427-435.
21. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 1999;281:1822-1829.
22. Peyton CL, Schiffman M, Lorincz AT, Hunt WC, Mielzynska I, Bratti C, Eaton S, Hildesheim A, Morera LA, Rodriguez AC, Herrero R, Sherman ME, Wheeler CM. Comparison of PCR-and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol 1998;36:3248-3254.
23. Sailors J, Gander R, Saboorian MH, Berkley P, Foster B, Ashfaq R. Stability of PreservCyt for Hybrid Capture (HC II) HPV test. Diagn Cytopathol 2005;32:260-263.
24. Solomon D, Schiffman M, Tarone R; ALTS Study group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-299.
25. Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006;55:1-94.
26. von Krogh G, Lacey CJ, Gross G, Barrasso R, Schneider A. European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Infect 2000;76:162-168.
27. Kaplan JE, Masur H, Holmes KK; USPHS; Infectious Disease Society of America. Guidelines for preventing opportunistic infections among HIV-infected persons - 2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep 2002;51:1-52.
28. Castle PE, Solomon D, Hildesheim A, Herrero R, Concepcion Bratti M, Sherman ME, Cecilia Rodriguez A, Alfaro M, Hutchinson ML, Terence Dunn S, Kuypers J, Schiffman M. Stability of archived liquid-based cervical cytologic specimens. Cancer 2003;99:89-96.
29. Fremont-Smith M, Marino J, Griffin B, Spencer L, Bolick D. Comparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study. Cancer 2004;102:269-279.
30. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance Am J Obstet Gynecol 1995;172:946-954.
31. Morin C, Bairati I, Bouchard C, Fortier M, Roy M, Moore L, Meisels A. Managing atypical squamous cells of undetermined significance in Papanicolaou smears. J Reprod Med 2001;46:799-805.
32. Wang N, Emancipator SN, Rose P, Rodriguez M, Abdul-Karim FW. Histologic follow-up of atypical endocervical cells. Liquid-based, thin-layer preparation vs. conventional Pap smear. Acta Cytol 2002;46:453-457.
33. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, Young N; Forum Group Members; Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-2119.
34. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ; ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-2129.
35. Algorithms for the management of abnormal cervical cytology. American Society for Colposcopy and Cervical Pathology Web site. Available at: http://www.asccp.org/pdfs/consensus/algorithms.pdf. Accessed January 24, 2007.
36. Wright TC Jr, Cox JT, Massad LS, Carlson J, Twiggs LB, Wilkinson EJ; American Society for Colposcopy and Cervical Pathology. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol 2003;189:295-304.
37. American Society for Colposcopy and Cervical Pathology. Algorithms for the management of biopsy confirmed cervical intraepithelial neoplasia. Available at: http://www.asccp.org/pdfs/consensus/algorithms.pdf. Accessed June 20, 2007.
38. Evans MF, Adamson CS, Papillo JL, St John TL, Leiman G, Cooper K. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. Cancer 2006;106:1054-1064.
39. Koutsky LA, AuIt KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU; Proof of Principle Study Investigators. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002;347:1645-1651.
40. Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, De Carvalho NS, Roteli-Martins CM, Teixeira J, Blatter MM, Korn AP, Quint W, Dubin G; GlaxoSmithKline HPV Vaccine Study Group. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004;364:1757-1765.
41. Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, Wheeler CM, Koutsky LA, Malm C, Lehtinen M, Skjeldestad FE, Olsson SE, Steinwall M, Brown DR, Kurman RJ, Ronnett BM, Staler MH, Ferenczy A, Harper DM, Tamms GM, Yu J, Lupinacci L, Railkar R, Taddeo FJ, Jansen KU, Esser MT, Sings HL, Saah AJ, Barr E. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005;6:271-278.
42. Merck news item. Merck's investigational vaccine Gardasil™ prevented 100 percent of cervical pre-cancers and non-invasive cervical cancers associated with HPV types 16 and 18 in new clinical study. Available at: http://www.merck.com/newsroom/press_releases/research_and_development/2005_1006. html. Accessed January 26, 2007.
43. FDA Licenses New Vaccine for Prevention of Cervical Cancer and Other Diseases in Females Caused by Human Papillomavirus. U.S. Food and Drug Administration Web site. Available at: http://www.fda.gov/bbs/topics/NEWS/2006/ NEW01385.html. Accessed September 12, 2006.
44. CDCs Advisory Committee Recommends Human Papillomavirus Virus Vaccination. CDC Web site. Available at: http://www.merck.com/newsroom/ press_releases/research_and_development/. Accessed September 12, 2006.
45. Bodaghi S, Yamanegi K, Xiao SY, Da Costa M, Palefsky JM, Zheng ZM. Colorectal papillomavirus infection in patients with colorectal cancer. Clin Cancer Res 2005;11:2862-2867.
46. Sotlar K, Koveker G, Aepinus C, Selinka HC, Kandolf R, Bultmann B. Human papillomavirus type 16-associated primary squamous cell carcinoma of the rectum. Gastroenterology 2001;120:988-994.
47. Koulos J, Symmans F, Chumas J, Nuovo G. Human papillomavirus detection in adenocarcinoma of the anus. Mod Pathol 1991;4:58-61.
48. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, Carter JJ, Porter PL, Galloway DA, McDougall JK, Krieger JN. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer 2005;116:606-616.
49. Rubin MA, Kleter B, Zhou M, Ayala G, Cubilla AL, Quint WG, Pirog EC. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol 2001;159:1211-1218.
50. Gross G, Pfister H. Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. Med Microbiol Immunol 2004;193:35-44.
51. Nagano H, Yoshikawa H, Kawana T, Yokota H, Taketani Y, Igarashi H, Yoshikura H, Iwamoto A. Association of multiple human papillomavirus types with vulvar neoplasias. J Obstet Gynaecol Res 1996;22:1-8.
52. Daling JR, Madeleine MM, Schwartz SM, Shera KA, Carter JJ, McKnight B, Porter PL, Galloway DA, McDougall JK, Tamimi H. A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 2002;84:263-270.
53. Srodon M, Staler MH, Baber GB, Kurman RJ. The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN). Am J Surg Pathol 2006;30:1513-1518.
54. Della Torre G, Donghi R, Longoni A, Pilotti S, Pasquini G, De Palo G, Pierotti MA, Rilke F, Della Porta G. HPV DNA in intraepithelial neoplasia and carcinoma of the vulva and penis. Diagn Mol Pathol 1992;1:25-30.